The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
Open accessAbstract
The sirtuin gene family (SIRT) is hypothesized to regulate the aging process and play a role in cellular repair. This work demonstrates that SIRT3(-/-) mouse embryonic fibroblasts (MEFs) exhibit abnormal mitochondrial physiology as well as increases in stress-induced superoxide levels and genomic instability. Expression of a single oncogene (Myc or Ras) in SIRT3(-/-) MEFs results in in vitro transformation and altered intracellular metabolism. Superoxide dismutase prevents transformation by a single oncogene in SIRT3(-/-) MEFs and reverses the tumor-permissive phenotype as well as stress-induced genomic instability. In addition, SIRT3(-/-) mice develop ER/PR-positive mammary tumors. Finally, human breast and other human cancer specimens exhibit reduced SIRT3 levels. These results identify SIRT3 as a genomically expressed, mitochondria-localized tumor suppressor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our finding that loss of SIRT3 loss drives senescence appears to contradict a report in which cells from SIRT3 knockout mice were highly susceptible to oncogenic transformation; however, this susceptibility depended on the elevated ROS characteristic of sirt3−/− cells (Kim et al., 2010).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Kim et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the genes encoding SIRT3 and SIRT6 are tumor suppressors”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Kim et al., 2010
Experimental — accuracy not yet measuredIn the citing paper
“SIRT3 has been reported as pro-apoptotic ((Allison and Milner 2007)) and SIRT3 loss is associated with a tumor-permissive environment via the inhibition of ROS production ((Kim et al. 2010);(Bell et al. 2011);(Finley et al. 2011)).”
From The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications (2018) · cites this paper as Kim et al. 2010
In the citing paper
“Specifically, SirT3 deficiency alone is sufficient for the transformation of primary MEFs with Myc and/or RAS to from tumors in xenograft models.”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Kim and colleagues also demonstrated that SirT3−/− Myc/Ras MEFs exhibit increased glycolysis, decreased oxidative phosphorylation and increased ROS.”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Recently SirT3 was described to act as a mitochondrial localized tumor suppressor (Kim et al., 2010).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Previously, SirT3 has been demonstrated to act as a tumor suppressor by negatively regulating MnSOD/ROS-mediated genomic instability (Kim et al., 2010).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Another member of the sirtuin family, SIRT3, is critical to the maintenance of mitochondria and metabolism and controls ROS production during HSC aging29.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [29]
In the citing paper
“Likewise, mitochondrial function, largely regulated by sirtuins, not only affects stem cell functions directly but also causes secondary effects on ROS and nutrient-sensing activities, which further modulate stem cell phenotypes29,30,108,113,184.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [29]
In the citing paper
“Recent work demonstrates that mitochondrial ROS directly contribute to cellular transformation induced by either Ras or Myc overexpression.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“Moreover, Sirt3−/− murine fibroblasts display increased levels of mitochondrial ROS accumulation (compared to wild-type cells) when either Myc or Ras oncogenes are expressed.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“The NAD-dependent deacetylase sirtuin 3 (SIRT3) acts as a tumor suppressor through its regulation of FOXO activity and ROS maintenance 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“This ROS accumulation is associated with decreased flux through mitochondrial complexes I and III (possibly allowing for increased escape of electrons to O2), and reduced cellular levels of SOD2 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“Expression of SOD2 inhibited this oncogene-mediated transformation of Sirt3−/− cells, suggesting that mitochondrial ROS play an important role in the Sirt3−/− phenotype.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“These finding are consistent with observations in Sod2−/− fibroblasts, which like their Sirt3−/− counterparts, are capable of transformation with single oncogenes 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“Sirt3−/− cells become transformed after expression of either Myc or Ras, whereas wild-type cells require expression of both oncogenes.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“SIRT3 deacetylates FOXO3a, promoting its nuclear localization and transcriptional activation 40, 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×
“It has been previously shown that overexpression of Myc in primary cells results in massive programmed cell death, whereas overexpression of Ras induces premature senescence (Sebastian et al., 2005; Serrano et al., 1997).”
BackgroundCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Mitochondrial abnormalities associated with altered oxidative metabolism are observed in tumor cells in vitro and in vivo and appear to contribute to a chronic condition of oxidative stress (Hsu and Sabatini, 2008).”
BackgroundRhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,506
Self-citationSir2 mediates longevity in the fly through a pathway related to calorie restriction
Rogina, B., & Helfand, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404184101 · Cited by 1,361
Genetic pathways that regulate ageing in model organisms
Guarente, L., & Kenyon, C. J. (2000) · Nature · doi:10.1038/35041700 · Cited by 1,337
Cited by
Sorted by citations
Items 301–400 of 788
Role of SIRT1 in autoimmune demyelination and neurodegeneration
Martin, A., Tegla, C., Cudrici, C. D., Kruszewski, A. M., Azimzadeh, P. N., Boodhoo, D., Mekala, A. P., Rus, V., & Rus, H. (2014) · Immunologic Research · doi:10.1007/s12026-014-8557-5 · Cited by 67
Cellular Compartmentation and the Redox/Nonredox Functions of NAD +
Kulkarni, C. A., & Brookes, P. S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7722 · Cited by 68
Srivastava, S. P., Goodwin, J. E., Kanasaki, K., & Koya, D. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15087 · Cited by 64
Sack, M. N. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00199.2011 · Cited by 64
Down-regulation of SIRT3 promotes ovarian carcinoma metastasis
Dong, X., Jing, L., Wang, W., & Gao, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.098 · Cited by 64
Kelly, G. S. (2010) · PubMed · Cited by 63
Pyrroloquinoline quinone increases the expression and activity of Sirt1 and -3 genes in HepG2 cells
Zhang, J., Meruvu, S., Bedi, Y. S., Chau, J., Arguelles, A. O., Rucker, R. B., & Choudhury, M. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.06.014 · Cited by 62
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Bel’skaya, L. V., & Dyachenko, E. I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050282 · Cited by 71
Madsen, C. T., Sylvestersen, K. B., Young, C., Buch-Larsen, S. C., Poulsen, J. W., Agerholm, M., Palmqvist, E. A., Hey‐Mogensen, M., Jensen, P. B., Treebak, J. T., et al. (2015) · Nature Communications · doi:10.1038/ncomms8726 · Cited by 61
Sánchez‐Aragó, M., Formentini, L., & Cuezva, J. M. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4883 · Cited by 63
Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis
Wu, L. E., Gomes, A. P., & Sinclair, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.005 · Cited by 62
Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease
Pugazhenthi, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.016 · Cited by 65
Jian, Y., Yang, Y., Cheng, L., Yang, X., Liu, H., Li, W., Wan, Y., & Yang, D. (2022) · Cell Proliferation · doi:10.1111/cpr.13362 · Cited by 61
Alhazzazi, T. Y., Kamarajan, P., Xu, Y., Ai, T., Chen, L., Verdin, E. M., & Kapila, Y. L. (2016) · PubMed · Cited by 61
Kim, Y. S., Vallur, P. G., Jones, V. M., Worley, B. L., Shimko, S., Shin, D., Crawford, L. C., Chen, C., Aird, K. M., Abraham, T., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1097-7 · Cited by 63
Favero, G., Trapletti, V., Bonomini, F., Stacchiotti, A., Lavazza, A., Rodella, L. F., & Rezzani, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071389 · Cited by 60
Liu, L., Xie, B., Fan, M., Candas, D., Jiang, J. X., Wei, R., Wang, Y., Chen, H.-W., Hu, Y., & Li, J. J. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.11.012 · Cited by 60
Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair
Van Meter, M., Mao, Z., Gorbunova, V., & Seluanov, A. (2011) · Aging · doi:10.18632/aging.100389 · Cited by 80
After the grape rush: Sirtuins as epigenetic drug targets in neurodegenerative disorders
Huber, K., & Superti‐Furga, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.018 · Cited by 60
Campisano, S., la Colla, A. B., Echarte, S. M., & Chisari, A. N. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422418000239 · Cited by 59
Anticancer Agents Targeted to Sirtuins
Kozako, T., Suzuki, T., Yoshimitsu, M., Arima, N., Honda, S., & Soeda, S. (2014) · Molecules · doi:10.3390/molecules191220295 · Cited by 61
Singh, S., Kumar, P., Thakur, S., Kiran, S., Sen, B., Sharma, S., Rao, V. V., Poongothai, A., & Ramakrishna, G. (2015) · Tumor Biology · doi:10.1007/s13277-015-3300-y · Cited by 59
Natural Products as Modulators of Sirtuins
Karaman, B., Sippl, W., & Ntie‐Kang, F. (2020) · Molecules · doi:10.3390/molecules25143287 · Cited by 60
Far Beyond the Usual Biomarkers in Breast Cancer: A Review
Pultz, B. D. A., da Luz, F. A. C., de Faria, P. R., Oliveira, A. P. L., de Araújo, R. A., & Silva, M. J. B. (2014) · Journal of Cancer · doi:10.7150/jca.8925 · Cited by 61
Liang, Q., Benavides, G. A., Vassilopoulos, A., Gius, D. R., Darley-Usmar, V. M., & Zhang, J. (2013) · Biochemical Journal · doi:10.1042/bj20130414 · Cited by 58
Self-citationZhu, Y., Zou, X., Dean, A. E., Brien, J. O., Gao, Y., Tran, E. L., Park, S., Liu, G., Kieffer, M. B., Jiang, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10352-4 · Cited by 60
Self-citationSirtuin modulators: where are we now? A review of patents from 2015 to 2019
Mautone, N., Zwergel, C., Mai, A., & Rotili, D. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1749264 · Cited by 57
Wang, X., Shao, Y., Ma, C., Chen, W., Sun, L., Liu, W., Zhang, D., Fu, B., Liu, K., Jia, Z., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12395 · Cited by 56
Patra, S., Panigrahi, D. P., Praharaj, P. P., Bhol, C. S., Mahapatra, K. K., Mishra, S. R., Behera, B. P., Jena, M., & Bhutia, S. K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03098-1 · Cited by 59
The role of SIRT3 in homeostasis and cellular health
Trinh, D., Halabi, L. A., Brar, H., Kametani, M., & Nash, J. E. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1434459 · Cited by 57
New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity
Soto, S. M., Vaz, E., Dell’Aversana, C., Álvarez, R., Altucci, L., & de Lera, Á. R. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06695e · Cited by 57
Owczarz, M., Budzińska, M., Domaszewska-Szostek, A., Borkowska, J., Połosak, J., Gewartowska, M., Ślusarczyk, P., & Puzianowska‐Kuźnicka, M. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217720884 · Cited by 55
Mitochondrial Sirtuins in Parkinson’s Disease
He, L., Wang, J., Yang, Y., Li, J., & Tu, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03560-w · Cited by 55
Mitochondrial and skeletal muscle health with advancing age
Konopka, A. R., & Nair, K. S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.008 · Cited by 57
SIRT1‐SIRT3 Axis Regulates Cellular Response to Oxidative Stress and Etoposide
Carnevale, I., Pellegrini, L., D’Aquila, P., Saladini, S., Lococo, E., Polletta, L., Vernucci, E., Foglio, E., Coppola, S., Sansone, L., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25711 · Cited by 51
Sishc, B. J., Ding, L., Nam, T.-K., Heer, C. D., Rodman, S. N., Schoenfeld, J. D., Fath, M. A., Saha, D., Pulliam, C. F., Langen, B., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3768 · Cited by 51
Self-citationLü, J., Cheng, K., Zhang, B., Xu, H., Cao, Y., Guo, F., Feng, X., & Xia, Q. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.011 · Cited by 52
Yang, B. L., Fu, X., Shao, L., Ding, Y., & Zeng, D. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.068 · Cited by 52
Mitochondrial Acetylation and Diseases of Aging
Wagner, G. R., & Payne, R. M. (2011) · Journal of Aging Research · doi:10.4061/2011/234875 · Cited by 52
Liu, P., Zou, D., Chen, K., Zhou, Q., Gao, Y., Huang, Y., Zhu, J., Zhang, Q., & Mi, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9627-y · Cited by 52
Shi, Q., Liu, T., Zhang, X., Geng, J., He, X., Nu, M., & Pang, D. (2016) · Oncology Letters · doi:10.3892/ol.2016.5021 · Cited by 52
Sengupta, A., & Haldar, D. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.11.003 · Cited by 53
Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets
Bruzzone, S., Parenti, M. D., Grozio, A., Ballestrero, A., Bauer, I., Río, A. D., & Nencioni, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581954 · Cited by 53
Fan, X., He, Y., Wu, G., Chen, H., Cheng, X., Zhan, Y., An, C., Chen, T., & Wang, X. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119411 · Cited by 53
Poljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 56
Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer
Zhao, Y., Yang, H., Wang, X., Zhang, R., Wang, C., & Guo, Z. (2013) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2013.06.001 · Cited by 50
SUMOylation-Mediated Response to Mitochondrial Stress
He, J., Cheng, J., & Wang, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165657 · Cited by 56
Liu, L., Yu, L., Zeng, C., Long, H., Duan, G., Yin, G., Dai, X., & Lin, Z. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00257-19 · Cited by 51
Sirtuin 3: A Janus face in cancer (Review)
Xiong, Y., Wang, M., Zhao, J., Han, Y., & Jia, L. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3767 · Cited by 50
Targeting aberrant cancer metabolism – The role of sirtuins
Kleszcz, R., Paluszczak, J., & Baer‐Dubowska, W. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.021 · Cited by 51
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 49
Zhang, T., Wang, L., Duan, X., Niu, Y., Li, M., Li, Y., Sun, H., Ma, Y., & Guo, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1281213 · Cited by 53
Are sirtuin deacylase enzymes important modulators of mitochondrial energy metabolism?
Osborne, B., Cooney, G. J., & Turner, N. A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.08.016 · Cited by 47
SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells
Yao, W., Gao, W., Xue, Y.-N., Zhang, L., Zhang, J., Lu, S.-Y., Yan, X.-Y., Yu, H., Su, J., & Sun, L. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.030 · Cited by 48
The dual role of sirtuins in cancer: biological functions and implications
Yu, L., Li, Y., Song, S., Zhang, Y., Wang, Y., Wang, H., Yang, Z., & Wang, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1384928 · Cited by 47
SIRT3 gene expression: A link between inherited mitochondrial DNA variants and oxidative stress
D’Aquila, P., Rose, G., Panno, M. L., Passarino, G., & Bellizzi, D. (2012) · Gene · doi:10.1016/j.gene.2012.01.042 · Cited by 47
Sirtuins, Bioageing, and Cancer
McGuinness, D. H., McGuinness, D. H., McCaul, J. A., & Shiels, P. G. (2011) · Journal of Aging Research · doi:10.4061/2011/235754 · Cited by 48
Mitochondrial sirtuins in the heart
Bugger, H., Witt, C. N., & Bode, C. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9570-7 · Cited by 47
Cancer Etiology: A Metabolic Disease Originating from Life’s Major Evolutionary Transition?
Poljšak, B., Kovač, V., Dahmane, R. G., Levec, T., & Starc, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7831952 · Cited by 48
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation
Morrison, A. J. (2021) · FEBS Journal · doi:10.1111/febs.16032 · Cited by 47
Cheresh, P., Kim, S.-J., Jablonski, R. P., Watanabe, S., Lu, Z., Chi, M., Helmin, K. A., Gius, D. R., Budinger, G. R. S., & Kamp, D. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136856 · Cited by 48
Self-citationInsights into regulators of p53 acetylation
Nagasaka, M., Miyajima, C., Aoki, H., Aoyama, M., Morishita, D., Inoue, Y., & Hayashi, H. (2022) · Cells · doi:10.3390/cells11233825 · Cited by 45
SOD2 and the Mitochondrial UPR: Partners Regulating Cellular Phenotypic Transitions
He, C., Hart, P. C., Germain, D., & Bonini, M. G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.04.004 · Cited by 48
Sun, W., Zhao, L., Song, X., Zhang, J., Xing, Y., Liu, N., Yan, Y., Li, Z., Lu, Y., Wu, J., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480417 · Cited by 47
Zhang, J., Zhu, Y., Hu, L., Fang, Y., & Chen, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-43731-4 · Cited by 46
Loss of Mitochondrial Control Impacts Renal Health
Srivastava, S. P., Kanasaki, K., & Goodwin, J. E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.543973 · Cited by 48
Regulation and protection of mitochondrial physiology by sirtuins
Pereira, C. V., Lebiedzińska, M., Wieckowski, M. R., & Oliveira, P. J. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.07.003 · Cited by 46
Rumpf, T., Gerhardt, S., Einsle, O., & Jung, M. (2015) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x15019986 · Cited by 44
Wu, X., Liu, M., Wei, G., Guan, Y., Duan, J., Xi, M., & Wang, J. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13234 · Cited by 45
Morris, G., Walder, K. R., Berk, M., Marx, W., Walker, A. J., Maes, M. H. J., & Puri, B. K. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05590-5 · Cited by 47
Zhao, Z., Wu, F., Ding, S., Sun, L., Liu, Z., Ding, K., & Lü, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2694-2 · Cited by 44
Zou, X., Santa-Maria, C. A., O’Brien, J., Gius, D. R., & Zhu, Y. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6641 · Cited by 44
Self-citationTao, N., Zhou, H., Tang, H., Cai, X.-F., Zhang, W., Ren, J., Zhou, L., Chen, X., Chen, K., Li, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10319 · Cited by 44
NAD+ in Cancer Prevention and Treatment: Pros and Cons
Poljšak, B. (2016) · Journal of Clinical & Experimental Oncology · doi:10.4172/2324-9110.1000165 · Cited by 45
Regulatory Effects of NAD + Metabolic Pathways on Sirtuin Activity
Zhang, N., & Sauve, A. A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.012 · Cited by 46
Metformin attenuates H2O2‑induced osteoblast apoptosis by regulating SIRT3 via the PI3K/AKT pathway
Yang, K., Pei, L., Zhou, S., Tao, L., & Zhu, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10751 · Cited by 44
The Many Faces of Sirtuins: Sirtuins and the Warburg effect
Guarente, L. (2014) · Nature Medicine · doi:10.1038/nm.3438 · Cited by 43
Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer
Cha, Y. I., & Kim, H.-S. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.9.180 · Cited by 43
Self-citationMitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer
Kim, H.-C., Chang, J., Lee, H. S., & Kwon, H. J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.152 · Cited by 42
Self-citationRewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
Pendleton, K. E., Wang, K., & Echeverria, G. V. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1254313 · Cited by 42
Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life
Pallavi, R., Giorgio, M., & Pelicci, P. G. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00318 · Cited by 40
Role of SIRT3 in the regulation of redox balance during oral carcinogenesis
Chen, I., Chiang, W., Liu, S.-Y., Chen, P., & Chiang, H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-68 · Cited by 43
Sirt1-Independent Mechanisms of the Putative Sirtuin Enzyme Activators SRT1720 and SRT2183
Huber, J. L., McBurney, M. W., DiStefano, P. S., & McDonagh, T. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.257 · Cited by 43
Fusaric acid induces mitochondrial stress in human hepatocellular carcinoma (HepG2) cells
Abdul, N. S., Nagiah, S., & Chuturgoon, A. A. (2016) · Toxicon · doi:10.1016/j.toxicon.2016.07.002 · Cited by 41
Lee, D., Jung, D., Yu, S. S., Lee, Y. S., Choi, B. K., & Lee, Y. C. (2017) · Oncotarget · doi:10.18632/oncotarget.18695 · Cited by 40
Zeng, H., He, X., & Chen, J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015895 · Cited by 41
Chen, P.-L., Chen, C.-F., Chen, Y., Guo, X. E., Huang, C.-K., Shew, J.-Y., Reddick, R. L., Wallace, D. C., & Lee, W.-H. (2012) · Oncogene · doi:10.1038/onc.2012.120 · Cited by 41
Dali‐Youcef, N., Froelich, S. C., Moussallieh, F., Chibbaro, S., Noël, G., Namer, I. J., Heikkinen, S., & Auwerx, J. H. (2015) · Scientific Reports · doi:10.1038/srep09087 · Cited by 43
Feng, L., Allen, T. K., Marinello, W. P., & Murtha, A. P. (2018) · Reproductive Sciences · doi:10.1177/1933719118776790 · Cited by 40
Icariin protects rotenone-induced neurotoxicity through induction of SIRT3
Zeng, R., Wang, X., Zhou, Q., Fu, X., Wu, Q., Lu, Y., Shi, J., Klaunig, J. E., & Zhou, S. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114639 · Cited by 40
Neeli, P. K., Gollavilli, P. N., Mallappa, S., Hari, S. G., & Kotamraju, S. (2019) · Oncogene · doi:10.1038/s41388-019-1126-6 · Cited by 40
Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer
Hur, H., Kim, Y., Ham, I., & Lee, D. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24043 · Cited by 40
Characterization of murine SIRT3 transcript variants and corresponding protein products
Yang, Y., Hubbard, B. P., Sinclair, D. A., & Tong, Q. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22795 · Cited by 40
The FOXO family of transcription factors: key molecular players in gastric cancer
Liu, Y., Ao, X., Jia, Y., Li, X., Wang, Y., & Wang, J. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02219-x · Cited by 39
The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications
Ouyang, S., Zhang, Q., Lou, L., Zhu, K., Li, Z., Liu, P., & Zhang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.871560 · Cited by 39
Li, Y., Kong, E., Ding, R., Chu, R., Lu, J., Deng, M., Tong, H., Yang, M., Wang, H., Chen, D., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14913 · Cited by 42
The role of mammalian sirtuins in cancer metabolism
Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 39
Metabolic regulation of Sirtuins upon fasting and the implication for cancer
Zhu, Y., Yan, Y., Gius, D. R., & Vassilopoulos, A. (2013) · Current Opinion in Oncology · doi:10.1097/01.cco.0000432527.49984.a3 · Cited by 43
Self-citationSIRT3 Expression as a Biomarker for Better Prognosis in Gastric Cancer
Huang, K., Hsu, C., Fang, W., Chi, C., Sung, M., Kao, H.-L., Li, A. F., Yin, P., Yang, M., & Lee, H. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2359-0 · Cited by 39
Xiang, X., Kang, J.-S., Yang, X., Su, J., Yao, W., Yan, X.-Y., Xue, Y.-N., Xu, Y., Liu, Y.-H., Yu, C., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3552 · Cited by 39
Metadata
- Authors
- Kim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., Vassilopoulos, A., Ozden, O., Park, S.-H., Singh, K. K., Abdulkadir, S. A., Spitz, D. R., Deng, C.-X., & Gius, D.
- Affiliations
- National Institutes of Health (US)
- Roswell Park Comprehensive Cancer Center (US)
- Vanderbilt University Medical Center (US)
- University of Iowa (US)
- Corresponding author
- Deng, Chu-Xia
- Gius, David
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 17
- Issue
- 1
- Pages
- 41-52
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3711519
- OpenAlex
- W2145755327
- Cited by
- 785
- References
- 35
- Citations by year
- 2026: 11 · 2025: 30 · 2024: 35 · 2023: 20 · 2022: 44 · 2021: 49 · 2020: 44 · 2019: 47 · 2018: 48 · 2017: 56 · 2016: 71 · 2015: 53 · 2014: 61 · 2013: 74 · 2012: 67
- FWCI
- 27.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (116430, R01 121904)
- National Institute on Aging (F30AG030839)
- National Cancer Institute (CA094858, CA123484, R01CA116430, R01CA094858, R01CA133114, R01CA100045, R01CA123484, R01CA121904, T32CA078586, P30CA086862)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- SIRT3, sirtuins, tumor suppressor, mitochondria, mitochondrial integrity, mitochondrial metabolism, superoxide, genomic instability, oncogenic transformation, c-Myc, Ras, superoxide dismutase, mammary tumors, breast cancer, cellular stress
- MeSH terms
- Aging, Animals, Breast Neoplasms, Cell Transformation, Neoplastic, Female, Fibroblasts, Humans, Immunohistochemistry, Mitochondria, Stress, Physiological, Superoxides, Genes, Tumor Suppressor, Mice, Knockout, Oxidative Stress, Mice, Sirtuin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
